Here’s a script combining slides 7 and 8, along with individual scripts for slides 6, 9, 11, and 12:
Slide 5: Absorption
“Absorption of drugs is generally not significantly affected by the normal aging process.
However, drug interactions can alter absorption. For example, antacids and iron can reduce
drug absorption. Additionally, certain diseases such as a lack of intrinsic factor can affect vitamin
B12 absorption, and delayed gastric emptying may impact how medications are processed.”
Slides 6: Distribution
“Drug distribution in the elderly is influenced by several physiological changes. Reduced lean
body mass and body water lead to a decreased volume of distribution, resulting in higher
concentrations of water-soluble drugs. In contrast, increased fat composition leads to a higher
volume of distribution, prolonging the half-life of fat-soluble drugs. Furthermore, lower levels of
serum proteins, such as albumin, increase the active, unbound concentration of drugs in the
bloodstream. These changes necessitate careful adjustment of drug dosages in older
individuals to avoid toxicity and ensure efficacy.”
Slide 7: Metabolism
“Metabolism of drugs by the liver often declines with age, primarily due to reduced liver capacity.
Phase I reactions, involving oxidation and reduction, are most affected, whereas Phase II
reactions remain largely unchanged. Reduced hepatic blood flow further contributes to changes
in drug clearance, especially for drugs with a high hepatic extraction ratio. Factors like liver
disease, malnutrition, and heart failure can Worsen these effects.”
Slide 8: Excretion
“The kidneys play a vital role in drug clearance, but renal function declines significantly with age.
Around two-thirds of the elderly population experience reduced creatinine clearance, despite
having normal serum creatinine levels due to decreased muscle mass. This can prolong drug
half-lives and increase the risk of toxicity if dosages are not appropriately adjusted.”